Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, Boutros PC, Cebon JS.

PLoS One. 2013 Jul 23;8(7):e67876. doi: 10.1371/journal.pone.0067876. Print 2013.

2.

Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.

Su C, Xu Y, Li X, Ren S, Zhao C, Hou L, Ye Z, Zhou C.

Int J Clin Exp Pathol. 2015 May 1;8(5):5509-18. eCollection 2015.

3.

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.

Gjerstorff MF, Pøhl M, Olsen KE, Ditzel HJ.

BMC Cancer. 2013 Oct 8;13:466. doi: 10.1186/1471-2407-13-466.

4.

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.

Yoshida N, Abe H, Ohkuri T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H, Nishimura T.

Int J Oncol. 2006 May;28(5):1089-98.

PMID:
16596224
5.

Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.

Grah JJ, Katalinic D, Juretic A, Santek F, Samarzija M.

Tumori. 2014 Jan-Feb;100(1):60-8. doi: 10.1700/1430.15817.

PMID:
24675493
6.

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer.

Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, Altorki NK.

Clin Cancer Res. 2005 Nov 15;11(22):8055-62.

7.
8.

Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.

Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Mizukami M, So T, Ichiki Y, Yasuda M, So T, Takenoyama M, Yasumoto K.

Lung Cancer. 2010 Apr;68(1):105-10. doi: 10.1016/j.lungcan.2009.05.010. Epub 2009 Jul 9.

PMID:
19545928
9.

MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy.

Napoletano C, Bellati F, Tarquini E, Tomao F, Taurino F, Spagnoli G, Rughetti A, Muzii L, Nuti M, Benedetti Panici P.

Am J Obstet Gynecol. 2008 Jan;198(1):99.e1-7. doi: 10.1016/j.ajog.2007.05.019.

PMID:
18166319
10.

Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.

Prasad ML, Jungbluth AA, Patel SG, Iversen K, Hoshaw-Woodard S, Busam KJ.

Head Neck. 2004 Dec;26(12):1053-7.

PMID:
15515159
11.

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.

Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.

Cancer Res. 2002 Jul 15;62(14):3971-9.

12.

The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer.

Konishi J, Toyooka S, Aoe M, Omura Y, Washio K, Tsukuda K, Shimizu N.

Oncol Rep. 2004 May;11(5):1063-7.

PMID:
15069548
13.

Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.

Kim SH, Lee S, Lee CH, Lee MK, Kim YD, Shin DH, Choi KU, Kim JY, Park DY, Sol MY.

Lung. 2009 Nov-Dec;187(6):401-11. doi: 10.1007/s00408-009-9181-3. Epub 2009 Oct 1.

PMID:
19795170
14.

Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study.

Matković B, Juretić A, Spagnoli GC, Separović V, Gamulin M, Separović R, Sarić N, Basić-Koretić M, Novosel I, Kruslin B.

Croat Med J. 2011 Apr 15;52(2):171-7.

15.

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.

Croat Med J. 2006 Feb;47(1):32-41.

16.

[Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].

Wang Y, Liang Z, Yuan YH, Han Y, Liu YX, Liu N, Chen YT, Ritter G, Old LJ, Zhang LJ.

Zhonghua Yi Xue Za Zhi. 2004 Mar 17;84(6):464-8. Chinese.

PMID:
15061963
17.

Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.

Zhou JX, Li Y, Chen SX, Deng AM.

J Exp Clin Cancer Res. 2011 Jan 6;30:2. doi: 10.1186/1756-9966-30-2.

18.

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.

Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, de Fraipont F, Brambilla E, Levallet J, Morin F, Westeel V, Wislez M, Quoix E, Debieuvre D, Dubois F, Rouquette I, Pujol JL, Moro-Sibilot D, Camonis J, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT).

Mol Cancer Ther. 2012 May;11(5):1203-13. doi: 10.1158/1535-7163.MCT-11-0899. Epub 2012 Mar 12.

19.

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA, Tsao MS.

J Clin Oncol. 2010 Oct 10;28(29):4417-24. doi: 10.1200/JCO.2009.26.4325. Epub 2010 Sep 7. Erratum in: J Clin Oncol. 2010 Dec 1;28(34):5126. J Clin Oncol. 2014 Feb 1;32(4):365.

20.

Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients.

Melloni G, Ferreri AJ, Russo V, Gattinoni L, Arrigoni G, Ceresoli GL, Zannini P, Traversari C.

Oncol Rep. 2004 Jul;12(1):145-51.

PMID:
15201976

Supplemental Content

Support Center